Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus

被引:117
作者
Leitao, MM
Sonoda, Y
Brennan, MF
Barakat, RR
Chi, DS
机构
[1] Mem Sloan Kettering Canc Ctr, Gynecol Serv, Acad Off, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Gastr & Mixed Tumor Serv, New York, NY 10021 USA
关键词
D O I
10.1016/S0090-8258(03)00478-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The purpose of this study was to determine the incidence of lymph node and ovarian metastases in newly diagnosed uterine leiomyosarcoma (LMS), and to describe possible predictive factors. Patients/methods. We used our prospectively acquired databases to identify 275 consecutive patients with uterine LMS treated from 7/82 to 12/01. Patients were included if there was clear documentation of lymph nodes and/or ovarian tissue in the pathologic reports. Clinical data were extracted from electronic medical records. Statistical analysis using the Fisher exact test was used to determine prognostic factors. Results. There were 108 patients (39.2%) identified in whom an oophorectomy and 37 patients (13.5%) in whom lymph node sampling was performed as part of the initial surgical management of uterine LMS. Bilateral oophorectomy was performed in 102 (94.4%) of the 108 patients. The median numbers of pelvic, para-aortic, and total lymph nodes acquired were 5 (range, 1-27), 3 (range, 1-9), and 6 (range, 1-34), respectively. Ovarian metastases were found in 4 (3.9%) out of 108 patients. Two (2.8%) of the 71 patients with disease confined to the uterus and/or cervix (stage I/II) and 2 (5.4%) of the 37 patients with gross extrauterine disease had ovarian metastases (P = 0.43). Positive lymph nodes were seen in 3 (8.1%) of 37 patients. No patients with stage I/II disease had positive lymph nodes (P = 0.015). None of the factors analyzed predicted for metastases to the ovary. Only the presence or absence of gross extrauterine disease correlated with lymph node metastasis. In addition, all three of these cases had clinically suspicious (enlarged) lymph nodes. Conclusion. The incidence of ovarian and lymph node metastases in uterine LMS is very low and is most commonly associated with extrauterine disease. Lymph node dissection for uterine LMS should be reserved for patients with clinically suspicious nodes. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:209 / 212
页数:4
相关论文
共 16 条
[1]   Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy [J].
AbuRustum, NR ;
Curtin, JP ;
Burt, M ;
Jones, WB .
OBSTETRICS AND GYNECOLOGY, 1997, 89 (05) :850-852
[2]  
BERCHUCK A, 1988, OBSTET GYNECOL, V71, P845
[3]   PROPENSITY OF RETROPERITONEAL LYMPH-NODE METASTASIS IN PATIENTS WITH STAGE I SARCOMA OF THE UTERUS [J].
CHEN, SS .
GYNECOLOGIC ONCOLOGY, 1989, 32 (02) :215-217
[4]   LYMPH-NODE METASTASIS FROM SOFT-TISSUE SARCOMA IN ADULTS - ANALYSIS OF DATA FROM A PROSPECTIVE DATABASE OF 1772 SARCOMA PATIENTS [J].
FONG, YM ;
COIT, DG ;
WOODRUFF, JM ;
BRENNAN, MF .
ANNALS OF SURGERY, 1993, 217 (01) :72-77
[5]   Uterine leiomyosarcoma: Analysis of treatment failures and survival [J].
Gadducci, A ;
Landoni, F ;
Sartori, E ;
Zola, P ;
Maggino, T ;
Lissoni, A ;
Bazzurini, L ;
Arisio, R ;
Romagnolo, C ;
Cristofani, R .
GYNECOLOGIC ONCOLOGY, 1996, 62 (01) :25-32
[6]  
GIUNTOLI RL, 2002, GYNECOL ONCOL, V84, P480
[7]   UTERINE LEIOMYOSARCOMA AND ENDOMETRIAL STROMAL SARCOMA - LYMPH-NODE METASTASES AND SITES OF RECURRENCE [J].
GOFF, BA ;
RICE, LW ;
FLEISCHHACKER, D ;
MUNTZ, HG ;
FALKENBERRY, SS ;
NIKRUI, N ;
FULLER, AF .
GYNECOLOGIC ONCOLOGY, 1993, 50 (01) :105-109
[8]  
HARLOW BL, 1986, J NATL CANCER I, V76, P399
[9]   OBSERVATIONS ON THE USE OF ADJUVANT RADIATION-THERAPY IN PATIENTS WITH STAGE-I AND STAGE-II UTERINE SARCOMA [J].
HORNBACK, NB ;
OMURA, G ;
MAJOR, FJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (12) :2127-2130
[10]  
Lewis J J, 1996, Curr Probl Surg, V33, P817